Revenue
2016
2017
2018
2019
2020
2021
2022
2023
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $18.1M | $13.4M | $5.9M | $2.4M | $3.7M | $1.7M | $3.5M | $3.0M | $1.8M | $240,206 | $4,140 | $2,805 | — |
| Gross profit | — | — | — | — | — | — | — | — | — | — | −$27,078 | $30,314 | $72,451 |
| Operating expenses | — | — | $9.1M | $1.8M | $3.4M | $1.9M | $4.6M | $3.2M | — | $2.7M | $52,508 | $90,425 | $71,881 |
| Operating income | −$4.0M | −$3.2M | −$3.0M | −$5.9M | −$8.9M | −$10.6M | −$7.0M | −$7.1M | −$7.2M | −$2.5M | −$20,341 | −$60,111 | $570 |
| EBITDAderived | −$3.1M | −$2.8M | −$2.5M | −$5.7M | −$8.7M | −$10.4M | −$6.9M | −$6.7M | −$7.0M | −$2.5M | — | — | — |
| Net income | −$7.1M | −$9.5M | −$8.9M | −$7.7M | −$15.5M | −$17.0M | −$8.2M | −$10.2M | −$8.8M | −$6.9M | −$20,323 | −$58,683 | −$726 |
| Basic EPSper diluted share | -$0.06 | -$0.10 | -$0.13 | -$0.17 | -$0.47 | -$0.49 | — | -$0.66 | -$0.63 | -$0.51 | $0.00 | -$0.01 | $0.00 |
| Diluted EPSper diluted share | -$0.06 | -$0.10 | -$0.13 | -$0.17 | -$0.47 | -$0.49 | -$0.40 | -$0.66 | -$0.63 | -$0.51 | $0.00 | -$0.01 | $0.00 |
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Nov 8, 2024Form 4 | TCM Tactical Opportunities Fund II LP +1TenPercentOwner | BuyWarrants · derivative | 2.50M | — | — | 2.50M |
| Nov 8, 2024Form 4 | TCM Tactical Opportunities Fund II LP +1TenPercentOwner | BuyWarrants · derivative | 4.91M | — | — | 4.91M |
| Nov 8, 2024Form 4 | TCM Tactical Opportunities Fund II LP +1TenPercentOwner | BuyWarrants · derivative | 1.04M | — | — | 1.04M |
| Nov 8, 2024Form 4 | TCM Tactical Opportunities Fund II LP +1TenPercentOwner | BuyWarrants · derivative | 592.9K | — | — | 592.9K |